
### [NCIT:C4216](http://purl.obolibrary.org/obo/NCIT_C4216)
**Label:** Sympathetic Paraganglioma

**Subclasses:** [NCIT:C5328](http://purl.obolibrary.org/obo/NCIT_C5328) (Extra-Adrenal Retroperitoneal Paraganglioma), [NCIT:C6416](http://purl.obolibrary.org/obo/NCIT_C6416) (Malignant Bladder Paraganglioma), [NCIT:C27279](http://purl.obolibrary.org/obo/NCIT_C27279) (Localized Adrenal Gland Pheochromocytoma), [NCIT:C48576](http://purl.obolibrary.org/obo/NCIT_C48576) (Extra-Adrenal Sympathetic Paraganglioma), [NCIT:C3326](http://purl.obolibrary.org/obo/NCIT_C3326) (Adrenal Gland Pheochromocytoma), [NCIT:C6414](http://purl.obolibrary.org/obo/NCIT_C6414) (Bladder Paraganglioma), [NCIT:C4220](http://purl.obolibrary.org/obo/NCIT_C4220) (Malignant Adrenal Gland Pheochromocytoma), [NCIT:C48305](http://purl.obolibrary.org/obo/NCIT_C48305) (Benign Adrenal Gland Pheochromocytoma), [NCIT:C8047](http://purl.obolibrary.org/obo/NCIT_C8047) (Recurrent Adrenal Gland Pheochromocytoma), [NCIT:C8045](http://purl.obolibrary.org/obo/NCIT_C8045) (Regional Adrenal Gland Pheochromocytoma), [NCIT:C92184](http://purl.obolibrary.org/obo/NCIT_C92184) (Malignant Adrenal Gland Composite Pheochromocytoma), [NCIT:C8046](http://purl.obolibrary.org/obo/NCIT_C8046) (Metastatic Adrenal Gland Pheochromocytoma), [NCIT:C48306](http://purl.obolibrary.org/obo/NCIT_C48306) (Adrenal Gland Composite Pheochromocytoma), [NCIT:C92181](http://purl.obolibrary.org/obo/NCIT_C92181) (Benign Adrenal Gland Composite Pheochromocytoma), [NCIT:C118822](http://purl.obolibrary.org/obo/NCIT_C118822) (Childhood Adrenal Gland Pheochromocytoma), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C48431](http://purl.obolibrary.org/obo/NCIT_C48431) (Neural Crest-Derived Cell) 53.12%
- [CL:0002371](http://purl.obolibrary.org/obo/CL_0002371) (somatic cell) and [NCIT:C42050](http://purl.obolibrary.org/obo/NCIT_C42050) (Neuroectodermal Cell) 53.12%
- [CL:0002077](http://purl.obolibrary.org/obo/CL_0002077) (ecto-epithelial cell) and [NCIT:C42050](http://purl.obolibrary.org/obo/NCIT_C42050) (Neuroectodermal Cell) 53.12%
- [CL:0000710](http://purl.obolibrary.org/obo/CL_0000710) (neurecto-epithelial cell) and [NCIT:C42050](http://purl.obolibrary.org/obo/NCIT_C42050) (Neuroectodermal Cell) 53.12%
- [CL:0000393](http://purl.obolibrary.org/obo/CL_0000393) (electrically responsive cell) and [NCIT:C42050](http://purl.obolibrary.org/obo/NCIT_C42050) (Neuroectodermal Cell) 53.12%
- [CL:0000211](http://purl.obolibrary.org/obo/CL_0000211) (electrically active cell) and [NCIT:C42050](http://purl.obolibrary.org/obo/NCIT_C42050) (Neuroectodermal Cell) 53.12%
- [CL:0000165](http://purl.obolibrary.org/obo/CL_0000165) (neuroendocrine cell) and [NCIT:C42050](http://purl.obolibrary.org/obo/NCIT_C42050) (Neuroectodermal Cell) 53.12%
- [CL:0000163](http://purl.obolibrary.org/obo/CL_0000163) (endocrine cell) and [NCIT:C42050](http://purl.obolibrary.org/obo/NCIT_C42050) (Neuroectodermal Cell) 53.12%
- [CL:0000151](http://purl.obolibrary.org/obo/CL_0000151) (secretory cell) and [NCIT:C42050](http://purl.obolibrary.org/obo/NCIT_C42050) (Neuroectodermal Cell) 53.12%
- [CL:0000075](http://purl.obolibrary.org/obo/CL_0000075) (columnar/cuboidal epithelial cell) and [NCIT:C42050](http://purl.obolibrary.org/obo/NCIT_C42050) (Neuroectodermal Cell) 53.12%
- [CL:0000066](http://purl.obolibrary.org/obo/CL_0000066) (epithelial cell) and [NCIT:C42050](http://purl.obolibrary.org/obo/NCIT_C42050) (Neuroectodermal Cell) 53.12%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) and [NCIT:C42050](http://purl.obolibrary.org/obo/NCIT_C42050) (Neuroectodermal Cell) 53.12%
- [NCIT:C42050](http://purl.obolibrary.org/obo/NCIT_C42050) (Neuroectodermal Cell) 38.48%
- [NCIT:C42050](http://purl.obolibrary.org/obo/NCIT_C42050) (Neuroectodermal Cell) and (not ([NCIT:C3998](http://purl.obolibrary.org/obo/NCIT_C3998) (Recurrent Colon Carcinoma))) 38.48%


